Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
AI tools may support improved detection of immunotherapy toxicities
Artificial intelligence (AI) approaches may help improve identification and monitoring of immune-related adverse events associated…
AI may reshape cancer care from screening to drug discovery
Artificial intelligence (AI) is increasingly being applied across the cancer care pathway, from early detection…
“Electronic nose” may help identify ovarian cancer signatures from blood samples
A machine-learning–enabled “electronic nose” capable of identifying ovarian cancer–associated signatures from blood plasma samples has…
Season 2 – Episode 3: Getting Exercise to Improve Cancer Survival? Challenge Accepted!
Join Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM for Series 2 of Supportive Care Matter. “If it were a pill, we would all want it.” This powerful opening statement captures the essence of ground-breaking research that’s transforming our understanding of cancer survivorship care: exercise. In this episode, Bogda chats to Professor Haryana Dhillon and Professor Janette Vardy about the CHALLENGE study.
Combining radiation and immunotherapy shows promise for bladder cancer
- Exosomal lnc-TAF12–2:1 identified as a novel diagnostic and therapeutic biomarker in bladder cancer
- TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
- TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer
Building the AI-enabled medical school of the future: A new era in clinician education?
In a viewpoint letter published in JAMA on 31 March 2025, Marc D. Succi, Bernard S. Chang and Arya S.…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.